The 12 analysts offering 12-month price forecasts for IVERIC bio Inc have a median target of 25.50, with a high estimate of 30.00 and a low estimate of 12.00. The median estimate represents a +89.31% increase from the last price of 13.47.
The current consensus among 12 polled investment analysts is to Buy stock in IVERIC bio Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.40
Reporting Date Nov 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.